Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.34 |
| ▸ | RORC | P51449 | 7/20 | 0.32 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | G6PD | P11413 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | TDP2 | O95551 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21687554 | 0.96 | PTGER4 (0.33) | PTGER4ENPP3ALDH1A1KDM4EGLA | |
| SCHEMBL21688026 | 0.94 | PTGER4 (0.33) | PTGER4RORCENPP3ALDH1A1KDM4E | |
| SCHEMBL21687894 | 0.94 | PTGER4 (0.33) | PTGER4RORCENPP3ALDH1A1KDM4E | |
| SCHEMBL21687536 | 0.93 | PTGER4 (0.34) | PTGER4RORCENPP3ALDH1A1KDM4E | |
| SCHEMBL21688044 | 0.92 | PTGER4 (0.33) | PTGER4RORCENPP3ALDH1A1KDM4E | |
| SCHEMBL21687625 | 0.91 | ALDH1A1 (0.34) | PTGER4ENPP3ALDH1A1KDM4EGLA | |
| SCHEMBL21687843 | 0.91 | GABRA1 (0.34) | PTGER4RORCENPP3ALDH1A1KDM4E | |
| SCHEMBL21687491 | 0.91 | KDM4E (0.33) | ALDH1A1KDM4EGLAGAAG6PD | |
| SCHEMBL21687828 | 0.91 | PTGER4 (0.33) | PTGER4ENPP3ALDH1A1KDM4EGLA | |
| SCHEMBL21688008 | 0.91 | KDM4E (0.33) | ALDH1A1KDM4EGLAGAAG6PD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11201300-B2 | Condensed cyclic compound and organic light-emitting device including condensed cyclic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2021-12-14 | — | — | US | disclosed |
| US-20200044168-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200044168-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND | CRY1, CCNL2, CCNE2 | PTGER4 553/4885RORC 1486/4885ENPP3 3675/4885 |
| US-11201300-B2 | Condensed cyclic compound and organic light-emitting device including condensed cyclic compound | CRY1, CCNL2, CCNE2 | PTGER4 553/4885RORC 1486/4885ENPP3 3675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.